117 related articles for article (PubMed ID: 16129413)
1. Anti-analgesia of a selective NPFF2 agonist depends on opioid activity.
Roussin A; Serre F; Gouardères C; Mazarguil H; Roumy M; Mollereau C; Zajac JM
Biochem Biophys Res Commun; 2005 Oct; 336(1):197-203. PubMed ID: 16129413
[TBL] [Abstract][Full Text] [Related]
2. Biochemical anti-opioid action of NPFF2 receptors in rat spinal cord.
Gouardères C; Zajac JM
Neurosci Res; 2007 May; 58(1):91-4. PubMed ID: 17337079
[TBL] [Abstract][Full Text] [Related]
3. Modulation of basal and morphine-induced neuronal activity by a NPFF(2) selective agonist measured by c-Fos mapping of the mouse brain.
Moulédous L; Frances B; Zajac JM
Synapse; 2010 Sep; 64(9):672-81. PubMed ID: 20336629
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells.
Mollereau C; Mazarguil H; Zajac JM; Roumy M
Mol Pharmacol; 2005 Mar; 67(3):965-75. PubMed ID: 15608144
[TBL] [Abstract][Full Text] [Related]
5. Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists.
Quelven I; Roussin A; Zajac JM
Eur J Pharmacol; 2005 Jan; 508(1-3):107-14. PubMed ID: 15680260
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist.
Fang Q; Wang YQ; He F; Guo J; Guo J; Chen Q; Wang R
Regul Pept; 2008 Apr; 147(1-3):45-51. PubMed ID: 18276024
[TBL] [Abstract][Full Text] [Related]
7. Endogenous mammalian RF-amide peptides, including PrRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptors.
Elhabazi K; Humbert JP; Bertin I; Schmitt M; Bihel F; Bourguignon JJ; Bucher B; Becker JA; Sorg T; Meziane H; Petit-Demoulière B; Ilien B; Simonin F
Neuropharmacology; 2013 Dec; 75():164-71. PubMed ID: 23911743
[TBL] [Abstract][Full Text] [Related]
8. Study of the N-terminal part of peptidic selective NPFF₂ agonists.
Mazarguil H; Mollereau C; Czaplicki G; Zajac JM
Peptides; 2012 Sep; 37(1):157-60. PubMed ID: 22813580
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of the mouse NPFF2 receptor.
Talmont F; Moulédous L; Piedra-Garcia L; Schmitt M; Bihel F; Bourguignon JJ; Zajac JM; Mollereau C
Peptides; 2010 Feb; 31(2):215-20. PubMed ID: 19944730
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist.
Bennett MA; Murray TF; Aldrich JV
J Pept Res; 2005 Mar; 65(3):322-32. PubMed ID: 15787962
[TBL] [Abstract][Full Text] [Related]
11. Staurosporine differentiation of NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells induces selectivity of NPFF activity towards opioid receptors.
Mollereau C; Zajac JM; Roumy M
Peptides; 2007 May; 28(5):1125-8. PubMed ID: 17418451
[TBL] [Abstract][Full Text] [Related]
12. Anti-opioid activities of NPFF1 receptors in a SH-SY5Y model.
Kersanté F; Mollereau C; Zajac JM; Roumy M
Peptides; 2006 May; 27(5):980-9. PubMed ID: 16488058
[TBL] [Abstract][Full Text] [Related]
13. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
14. Peripheral and central sites of action for anti-allodynic activity induced by the bifunctional opioid/NPFF receptors agonist BN-9 in inflammatory pain model.
Zhang R; Xu B; Zhang MN; Zhang T; Wang ZL; Zhao G; Zhao GH; Li N; Fang Q; Wang R
Eur J Pharmacol; 2017 Oct; 813():122-129. PubMed ID: 28755985
[TBL] [Abstract][Full Text] [Related]
15. Opposite control of body temperature by NPFF1 and NPFF2 receptors in mice.
Moulédous L; Barthas F; Zajac JM
Neuropeptides; 2010 Oct; 44(5):453-6. PubMed ID: 20554321
[TBL] [Abstract][Full Text] [Related]
16. GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.
Moulédous L; Froment C; Dauvillier S; Burlet-Schiltz O; Zajac JM; Mollereau C
J Biol Chem; 2012 Apr; 287(16):12736-49. PubMed ID: 22375000
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide FF receptors: structure-activity relationship and effect of morphine.
Payza K; Akar CA; Yang HY
J Pharmacol Exp Ther; 1993 Oct; 267(1):88-94. PubMed ID: 8229791
[TBL] [Abstract][Full Text] [Related]
18. Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice.
Fang Q; Jiang TN; Li N; Han ZL; Wang R
Protein Pept Lett; 2011 Apr; 18(4):403-9. PubMed ID: 21121889
[TBL] [Abstract][Full Text] [Related]
19. Opposite alterations of NPFF1 and NPFF2 neuropeptide FF receptor density in the triple MOR/DOR/KOR-opioid receptor knockout mouse brains.
Gouardères C; Kieffer BL; Zajac JM
J Chem Neuroanat; 2004 May; 27(2):119-28. PubMed ID: 15121216
[TBL] [Abstract][Full Text] [Related]
20. Rat NPFF(1) receptor-mediated signaling: functional comparison of neuropeptide FF (NPFF), FMRFamide and PFR(Tic)amide.
Chen JC; Lee WH; Chen PC; Tseng CP; Huang EY
Peptides; 2006 May; 27(5):1005-14. PubMed ID: 16490283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
